Clinical Trials Logo

Uterine Malignancies clinical trials

View clinical trials related to Uterine Malignancies.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT00687778 Recruiting - Lung Cancer Clinical Trials

11C-Acetate PET/CT Non-FDG-Avid Tumors

Start date: May 2008
Phase: N/A
Study type: Observational

F18-FDG is the widely used PET tracer in the routine practice of oncologic disease imaging using the technology of PET-CT. However, FDG-avidity is a characteristic of the individual tumor. There are various types of human malignancies, which are not taking FDG in access. In these cases FDG is not a sensitive tracer of imaging. In search for other tumor PET tracers, C11-Acetate has been shown recently in a few early studies to have a potential value in imaging of non-FDG-avid tumors. The purpose of the current study is to assess the role of 11C-acetate PET in various tumors, which often are not detected by 18F-FDG and were not widely assessed until now.